Four new 2-arylbenzofuran derivatives, cathafurans A (1), B (2), C (3), and D (4), were isolated from the stem bark of Morus cathayana. Their structures were determined by spectroscopic methods. Compounds 2 and 3 exhibited moderate activities against five human cancer cell lines, with IC(50) values ranging from 6.17 to 9.60 microg/mL.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/np800789y | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Benzofuran Derivatives from Cortex Mori Radicis and Their Cholinesterase-Inhibitory Activity.
Molecules
January 2024
College of Life Sciences and Agronomy, Zhoukou Normal University, Zhoukou 466001, China.
The phytochemical investigation of Cortex Mori Radicis led to the isolation and identification of a new prenylated benzofuranone () and four ring-opening derivatives (-) named albaphenol A-E, as well as nigranol A (), together with ten 2-arylbenzofuran derivatives (-). The characterization of the structures of the new compounds and the structural revision of nigranol A () were conducted using the comprehensive analysis of spectroscopic data (1D/2D NMR, HRESIMS, CD, and XRD). Compounds - were tested for their inhibitory effects on acetylcholinesterase (AChE) and butyrylcholinesterase (BChE).
View Article and Find Full Text PDFAn Arylbenzofuran, Stilbene Dimers, and Prenylated Diels-Alder Adducts as Potent Diabetic Inhibitors from Leaves.
Antioxidants (Basel)
March 2023
Department of Food Science and Human Nutrition, Jeonbuk National University, Jeonju 54896, Republic of Korea.
has a long history of usage as a treatment for metabolic diseases, especially, diabetes mellitus (DM). Thus, we aimed to isolate and evaluate bioactive constituents derived from leaves for the treatment of DM. According to bioassay-guided isolation by column chromatography, eight compounds were obtained from leaves: two phenolic compounds, -coumaric acid () and chlorogenic acid methyl ester (), one stilbene, oxyresveratrol (), two stilbene dimers, macrourin B () and austrafuran C (), one 2-arylbenzofuran, moracin M (), and two Diels-Alder type adducts, mulberrofuran F () and chalcomoracin ().
View Article and Find Full Text PDFTotal Synthesis of the Natural Chalcone Lophirone E, Synthetic Studies toward Benzofuran and Indole-Based Analogues, and Investigation of Anti-Leishmanial Activity.
Molecules
January 2022
Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy.
The potential of natural and synthetic chalcones as therapeutic leads against different pathological conditions has been investigated for several years, and this class of compounds emerged as a privileged chemotype due to its interesting anti-inflammatory, antimicrobial, antiviral, and anticancer properties. The objective of our study was to contribute to the investigation of this class of natural products as anti-leishmanial agents. We aimed at investigating the structure-activity relationships of the natural chalcone lophirone E, characterized by the presence of benzofuran B-ring, and analogues on anti-leishmania activity.
View Article and Find Full Text PDFSynthesis and biological evaluation of 2-arylbenzofuran derivatives as potential anti-Alzheimer's disease agents.
J Enzyme Inhib Med Chem
December 2021
Institute of Materia Medica, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Alzheimer's disease (AD) is a type of progressive dementia caused by degeneration of the nervous system. A single target drug usually does not work well. Therefore, multi-target drugs are designed and developed so that one drug can specifically bind to multiple targets to ensure clinical effectiveness and reduce toxicity.
View Article and Find Full Text PDFSynthesis of Moracin C and Its Derivatives with a 2-arylbenzofuran Motif and Evaluation of Their PCSK9 Inhibitory Effects in HepG2 Cells.
Molecules
March 2021
College of Pharmacy and Integrated Research Institute for Drug Development, Dongguk University, Seoul 04620, Korea.
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a key factor in several cardiovascular diseases, as it is responsible for the elevation of circulating low-density lipoprotein cholesterol (LDL-C) levels in blood plasma by direct interaction with the LDL receptor. The development of orally available drugs to inhibit this PCSK9-LDLR interaction is a highly desirable objective. Here, we report the synthesis of naturally occurring moracin compounds and their derivatives with a 2-arylbenzofuran motif to inhibit expression.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!